24 related articles for article (PubMed ID: 22814462)
1. Scalable Synthesis of a Key Intermediate for the Production of Pleuromutilin-Based Antibiotics.
Murphy SK; Zeng M; Herzon SB
Org Lett; 2017 Sep; 19(18):4980-4983. PubMed ID: 28858512
[TBL] [Abstract][Full Text] [Related]
2. Lefamulin: A Novel Semisynthetic Pleuromutilin Antibiotic for Community-acquired Bacterial Pneumonia.
Watkins RR; File TM
Clin Infect Dis; 2020 Dec; 71(10):2757-2762. PubMed ID: 32221520
[TBL] [Abstract][Full Text] [Related]
3. A Comprehensive Overview of the Antibiotics Approved in the Last Two Decades: Retrospects and Prospects.
Shi Z; Zhang J; Tian L; Xin L; Liang C; Ren X; Li M
Molecules; 2023 Feb; 28(4):. PubMed ID: 36838752
[TBL] [Abstract][Full Text] [Related]
4. Advances in MRSA drug discovery: where are we and where do we need to be?
Kurosu M; Siricilla S; Mitachi K
Expert Opin Drug Discov; 2013 Sep; 8(9):1095-116. PubMed ID: 23829425
[TBL] [Abstract][Full Text] [Related]
5. Disk diffusion and MIC quality control ranges for BC-3205 and BC-3781, two novel pleuromutilin antibiotics.
Ross JE; Sader HS; Ivezic-Schoenfeld Z; Paukner S; Jones RN
J Clin Microbiol; 2012 Oct; 50(10):3361-4. PubMed ID: 22814462
[TBL] [Abstract][Full Text] [Related]
6. Determination of Disk Diffusion and MIC Quality Control Ranges for Nafithromycin (WCK 4873), a New Lactone-Ketolide.
Hackel MA; Karlowsky JA; Dressel D; Sahm DF
J Clin Microbiol; 2017 Oct; 55(10):3021-3027. PubMed ID: 28747372
[TBL] [Abstract][Full Text] [Related]
7. Determination of disk diffusion and MIC quality control ranges for GSK1322322, a novel peptide deformylase inhibitor.
Ross JE; Scangarella-Oman NE; Miller LA; Sader HS; Jones RN
J Clin Microbiol; 2011 Nov; 49(11):3928-30. PubMed ID: 21918031
[TBL] [Abstract][Full Text] [Related]
8. Validation of cefditoren MIC quality control ranges by a multi-laboratory study (2001).
Jones RN; Biedenbach DJ;
Diagn Microbiol Infect Dis; 2001; 40(1-2):71-3. PubMed ID: 11448567
[TBL] [Abstract][Full Text] [Related]
9. Assessment of BMS284756 MIC and 5-microg disk diffusion quality control studies tested against seven American type culture collection strains.
Biedenbach DJ; Jones RN;
Diagn Microbiol Infect Dis; 2001 Dec; 41(4):225-8. PubMed ID: 11777665
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial activity of the pleuromutilin antibiotic BC-3781 against bacterial pathogens isolated in the SENTRY antimicrobial surveillance program in 2010.
Paukner S; Sader HS; Ivezic-Schoenfeld Z; Jones RN
Antimicrob Agents Chemother; 2013 Sep; 57(9):4489-95. PubMed ID: 23836172
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial activity of the novel pleuromutilin antibiotic BC-3781 against organisms responsible for community-acquired respiratory tract infections (CARTIs).
Sader HS; Paukner S; Ivezic-Schoenfeld Z; Biedenbach DJ; Schmitz FJ; Jones RN
J Antimicrob Chemother; 2012 May; 67(5):1170-5. PubMed ID: 22287234
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial activity of the investigational pleuromutilin compound BC-3781 tested against Gram-positive organisms commonly associated with acute bacterial skin and skin structure infections.
Sader HS; Biedenbach DJ; Paukner S; Ivezic-Schoenfeld Z; Jones RN
Antimicrob Agents Chemother; 2012 Mar; 56(3):1619-23. PubMed ID: 22232289
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
